The CpG island methylator phenotype in colorectal cancer

37Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

In summary, this elegant study by Ogino et al performs an essential validation of the findings of Weisenberger et al and also points to some differences with the previous study that may have implications for the interpretation of CIMP results in the work-up of HNPCC. Much work still needs to be done with respect to the optimal technique(s) and panel(s) for CIMP determination, but the diagnostic utility and epidemiology of this epigenetic change strongly support its significance in the biology of colorectal cancer. Copyright © American Society for Investigative Pathology and the Association for Molecular Pathology.

Cite

CITATION STYLE

APA

Samowitz, W. S. (2007). The CpG island methylator phenotype in colorectal cancer. Journal of Molecular Diagnostics. Association of Molecular Pathology. https://doi.org/10.2353/jmoldx.2007.070031

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free